1) relapsed or stubborn
复发或难治
1.
Objective To assess the antitumor efficacy and tolerance of combination chemotherapy with Mitoxantrone (MIT), Ifosphamide (IFO), Etoposide (VP-16) and Prednisone (PRED) for relapsed or stubborn non-Hodgkin s lymphoma.
目的 观察MIEP化疗方案治疗复发或难治非霍奇金淋巴瘤 (NHL)临床疗效和毒副作用。
3) refractory or recurrent
难治性或复发性
1.
Objective:To observe the efficacy and the side effect of ESHAP in the treatment of refractory or recurrent Non-Hodgkin\'s lymphoma (NHL).
目的:观察ESHAP方案治疗难治性或复发性非霍奇金淋巴瘤(NHL)的疗效及不良反应。
4) refractory-relapsed
复发难治
1.
Objective:To evaluate expression of the mdr1 gene and reversal of drug resistance on refractory-relapsed acute leukemia.
目的 :探讨复发难治性急性白血病多药耐药性及耐药性的逆转。
补充资料:后难
1.犹后患。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条